By Thyagaraju Adinarayan and Saikat Chatterjee
LONDON (Reuters) – News of a breakthrough in the race to find a COVID-19 vaccine sparked one of the heaviest trading days since the height of the pandemic crisis, according to early data analysed by Reuters, with nearly $2 trillion changing hands on Monday.
Traders stampeded to the riskier plays in equities, foreign exchange and bond markets after Pfizer Inc
“Volumes (are) also surging as programmes and baskets go to work to either correct portfolio balances or address margin calls,” said Mark Taylor, sales trader at Mirabaud Securities, highlighting a jump in volumes in the airlines and banking sectors.
In the United States, nearly $500 billion worth of trades went through stock markets on Monday, one of the busiest days since March, when coronavirus lockdown fears rattled financial markets. Europe saw $120 billion traded, according to Refinitiv data.
Value stocks, typically companies that are more sensitive to economic cycles, notched their best one-day performance against their growth-focused peers ever in the United States after Monday’s news of an effective vaccine against the coronavirus.
A similar trend was noticed in the bond and currency markets where volumes matched the panic trading seen during the depths of the market mayhem in March and double that of April when the coronavirus pandemic slammed into markets.
Total turnover for the 33 currency pairs on CLS, a major settler of trades in the currency markets, totalled $627 billion on Monday. Average daily turnover was $707 billion in March and $380 billion in April.
Bond market turnover also jumped. Nearly 170,000 contracts changed hands on the popular front-month German bund futures contracts , 1.5 times this year’s average, according to Refinitiv data.
Total turnover on German government bonds on Monday totalled nearly 9 billion euros ($10.63 billion), more than the average since the start of October, according to data from Marketaxess, a major trading platform.
(Reporting by Thyagaraju Adinarayan and Saikat Chatterjee; Editing by and Jonathan Oatis)
